Drugs / VAX2012Q
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02015494 | Mar → Dec 2014 | influenza | VaxInnate Corporation | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02247362 | Nov 2014 → Apr 2015 | influenza | VaxInnate Corporation | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02434276 | May → Aug 2015 | influenza | VaxInnate Corporation | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VAX2012Q | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02015494 ↗ |
| Modality | Vaccine | “A Quadrivalent Influenza Vaccine in Healthy Adults Age 18-40 Years” NCT02015494 ↗ |
| Route | Intramuscular | “Recombinant influenza HA vaccine delivered IM” NCT02015494 ↗ |